Literature DB >> 29138327

Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?

Homayon Ghiasi1.   

Abstract

Entities:  

Keywords:  HSV-1; ocular infection; vaccine

Mesh：

Substances：

Year:  2017        PMID： 29138327      PMCID： PMC5686747          DOI： 10.1128/JVI.01421-17

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  25 in total

1.  VACCINE THERAPY IN RECURRENT HERPES SIMPLEX.

Authors:  A B KERN; B L SCHIFF
Journal:  Arch Dermatol       Date:  1964-06

2.  Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences.

Authors:  L Kutinová; R Benda; Z Kalos; V Dbalý; T Votruba; E Kvícalová; P Petrovská; S Doutlík; J Kamínková; E Domorázková
Journal:  Vaccine       Date:  1988-06       Impact factor: 3.641

3.  Efficacy results of a trial of a herpes simplex vaccine.

Authors:  Robert B Belshe; Peter A Leone; David I Bernstein; Anna Wald; Myron J Levin; Jack T Stapleton; Iris Gorfinkel; Rhoda L Ashley Morrow; Marian G Ewell; Abbie Stokes-Riner; Gary Dubin; Thomas C Heineman; Joann M Schulte; Carolyn D Deal
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

4.  Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.

Authors:  J E Oakes; R N Lausch
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

5.  Clinical efficacy of a herpes simplex subunit vaccine.

Authors:  R Cappel; S Sprecher; F De Cuyper; J De Braekeleer
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

6.  Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.

Authors:  C Shimeld; T J Hill; W A Blyth; D L Easty
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

7.  Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.

Authors:  A B Nesburn; R L Burke; H Ghiasi; S Slanina; S Bahri; S L Wechsler
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis.

Authors:  G R Skinner; C Woodman; C Hartley; A Buchan; A Fuller; C Wiblin; G Wilkins; J Melling
Journal:  Dev Biol Stand       Date:  1982

9.  Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.

Authors:  M H Ritchie; J E Oakes; R N Lausch
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-07       Impact factor: 4.799

10.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

Authors:  F P Siegal; C Lopez; G S Hammer; A E Brown; S J Kornfeld; J Gold; J Hassett; S Z Hirschman; C Cunningham-Rundles; B R Adelsberg
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.